Trademark: 88359968
Word
AAVANTIBIO ADVANCING THERAPY FOR FRIEDREICH'S ATAXIA
Status Date
Monday, May 8, 2023
Filing Date
Wednesday, March 27, 2019
Published for Opposition
Tuesday, February 11, 2020
Abandoned Date
Monday, May 8, 2023
5 Biological treatments, namely, biological preparations, for use for clinical, medicinal and the therapeutic treatment of Friedreich's Ataxia and genetic disorders; biological preparations for the treatment of Friedreich's Ataxia and genetic disorders; Biospecific reagents for medical use, for use in immunotherapy for the treatment of Friedreich's Ataxia and genetic disorders; Biological preparations for use in immunotherapy for the treatment of Friedreich's Ataxia and genetic disorders; Biological preparations, namely, biological drugs in the nature of gene therapy products for use for clinical, medicinal and therapeutic treatment of Friedreich's Ataxia; biological preparations, namely, biological drugs in the nature of gene therapy products for treatment of genetic diseases and Friedreich's Ataxia; biological preparations, namely, biological drugs in the nature of gene therapy products for use in treating Friedreich's Ataxia and autoimmunity disorders and diseases; biological preparations, namely, gene therapy products in the nature of therapeutic pharmaceuticals for the treatment of Friedreich's Ataxia, autoimmune, immune system diseases and disorders; pharmaceutical preparations for human use for the treatment of Friedreich's Ataxia; Therapeutic pharmaceutical preparations and medical diagnostic agents and preparations for use in therapies for Friedreich's Ataxia and autoimmunity, all of the foregoing for medical use; Therapeutic pharmaceutical preparations and diagnostic agents, preparations and substances for medical purposes for targeting application to immunotherapies and therapeutic and diagnostic agents
The mark consists of the wording "AAVANTIBIO" with the crossbar of the first letter "A" forming a swoosh that ends to the left of the next letter "A" on a first line and the wording "Advancing Therapy for Friedreich's Ataxia" directly underneath.
Color is not claimed as a feature of the mark.
May 8, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
May 8, 2023
Abandonment - No Use Statement Filed
Feb 22, 2023
Assigned To Examiner
Oct 4, 2022
Notice Of Approval Of Extension Request E-Mailed
Oct 3, 2022
Sou Extension 5 Granted
Sep 27, 2022
Sou Extension 5 Filed
Sep 27, 2022
Sou Teas Extension Received
Apr 7, 2022
Notice Of Approval Of Extension Request E-Mailed
Apr 5, 2022
Sou Extension 4 Granted
Apr 5, 2022
Sou Extension 4 Filed
Apr 5, 2022
Sou Teas Extension Received
Sep 18, 2021
Notice Of Approval Of Extension Request E-Mailed
Sep 16, 2021
Sou Extension 3 Granted
Sep 16, 2021
Sou Extension 3 Filed
Sep 16, 2021
Sou Teas Extension Received
Sep 7, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Sep 7, 2021
Teas Change Of Correspondence Received
Sep 7, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 7, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 7, 2021
Teas Change Of Owner Address Received
Apr 21, 2021
Notice Of Approval Of Extension Request E-Mailed
Apr 20, 2021
Sou Extension 2 Granted
Apr 6, 2021
Sou Extension 2 Filed
Apr 20, 2021
Case Assigned To Intent To Use Paralegal
Apr 6, 2021
Sou Teas Extension Received
Oct 8, 2020
Notice Of Approval Of Extension Request E-Mailed
Oct 6, 2020
Sou Extension 1 Granted
Oct 6, 2020
Sou Extension 1 Filed
Oct 6, 2020
Sou Teas Extension Received
Apr 7, 2020
Noa E-Mailed - Sou Required From Applicant
Feb 11, 2020
Official Gazette Publication Confirmation E-Mailed
Feb 11, 2020
Published For Opposition
Jan 22, 2020
Notification Of Notice Of Publication E-Mailed
Jan 2, 2020
Approved For Pub - Principal Register
Dec 31, 2019
Examiner's Amendment Entered
Dec 31, 2019
Notification Of Examiners Amendment E-Mailed
Dec 31, 2019
Examiners Amendment E-Mailed
Dec 31, 2019
Examiners Amendment -Written
Dec 13, 2019
Teas/Email Correspondence Entered
Dec 12, 2019
Correspondence Received In Law Office
Dec 12, 2019
Teas Response To Office Action Received
Oct 2, 2019
Automatic Update Of Assignment Of Ownership
Jun 12, 2019
Notification Of Non-Final Action E-Mailed
Jun 12, 2019
Non-Final Action E-Mailed
Jun 12, 2019
Non-Final Action Written
Jun 6, 2019
Assigned To Examiner
Apr 15, 2019
New Application Office Supplied Data Entered
Mar 30, 2019
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
